menu
    • menu

    Company profile for HanX Biopharmaceuticals

    Rochem, your partner in developing, sourcing, and supplying pharmaceutical & animal health ingredients of Chinese origin.

    Virtual Booth

    Contact Supplier

    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2025-12-22

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    HTL Biotechnology is a French biotech & a global leader in the responsible development & production of pharma-grade biopolymers.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Established in 2016, Hanx Biopharmaceutical Co., Ltd. is a global biopharmaceutical company that develops innovative immune-oncology therapeutics. HanxBio brings together well-known experts in the biopharmaceutical industry advance the development of novel cancer medicines from early discovery, translational research, process development, cGMP manufacturing, business development, to clinical research. We leverage our expertise...
    Established in 2016, Hanx Biopharmaceutical Co., Ltd. is a global biopharmaceutical company that develops innovative immune-oncology therapeutics. HanxBio brings together well-known experts in the biopharmaceutical industry advance the development of novel cancer medicines from early discovery, translational research, process development, cGMP manufacturing, business development, to clinical research. We leverage our expertise to develop patented high-affinity long half-life antibody screening, rationally designed multi-functional molecule and novel tumor-targeting antibody technology platforms (GPSmAb).

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    HanX BiopharmaceuticalsChina Flag
    Country
    Country
    China
    Address
    Address
    No. 02, 16th Floor, Unit 2, Building 1, Block B, Optics Valley World City, Wes...
    Telephone
    Telephone
    +86 027-65524978
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    http://hanxbio.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Tides Asia

    Tides Asia

    Not Confirmed

    envelop Contact Supplier

    Tides Asia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Hanx Bio Announces 1st Dosing in Ph 1 Clinical Trial of HX044
    Hanx Bio Announces 1st Dosing in Ph 1 Clinical Trial of HX044

    02 Jan 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/hanx-biopharmaceuticals-ltd-announces-first-patient-dosing-in-first-in-human-phase-1-clinical-trial-of-hx044-302341401.html

    PR NEWSWIRE
    02 Jan 2025
    Share Share
    Crown Bioscience, HanX pact shows promise of lymphoma drug
    Crown Bioscience, HanX pact shows promise of lymphoma drug

    24 Aug 2023

    // Joseph Keenan FIERCE BIOTECH

    https://www.fiercebiotech.com/cro/crown-bioscience-hanx-pact-shows-promise-lymphoma-drug

    Joseph Keenan FIERCE BIOTECH
    24 Aug 2023
    Share Share
    Crown Bio Enables HanX Biopharmaceutical to Progress HX009 to Clinical Trials
    Crown Bio Enables HanX Biopharmaceutical to Progress HX009 to Clinical Trials

    22 Aug 2023

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20230822704578/en

    BUSINESSWIRE
    22 Aug 2023
    Share Share
    China-based HanX earns FDA greenlight for US lymphoma trial
    China-based HanX earns FDA greenlight for US lymphoma trial

    23 May 2023

    // CLINICAL TRIALS ARENA

    https://www.clinicaltrialsarena.com/news/china-based-hanx-earns-fda-greenlight-for-us-lymphoma-trial/

    CLINICAL TRIALS ARENA
    23 May 2023
    Share Share
    HanX Biopharmaceuticals announces HX009 IND approval from FDA
    HanX Biopharmaceuticals announces HX009 IND approval from FDA

    22 May 2023

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/hanx-biopharmaceuticals-announces-hx009-ind-approval-from-fda-301829760.html

    PR NEWSWIRE
    22 May 2023
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search